Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in terms of SEBI Circular No. SEBI / HO / MIRSD / MIRSD_RTAMB / P / CIR / 2022 / 8 dated January 25, 2022, Aurobindo Pharma has informed that the Company has approved the issuance of ‘Letter of Confirmations’ in lieu of duplicate share certificates, which were reported as lost by the shareholders: Subhas Kumar Patodia (Folio No: APL033412) & Aruna Ch (Folio No: APL027500), further details are enclosed.
The above information is a part of company’s filings submitted to BSE.
